Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Rocket Pharmaceuticals (RCKT) Other Gross PP&E Adjustments (2016 - 2025)

Rocket Pharmaceuticals' Other Gross PP&E Adjustments history spans 10 years, with the latest figure at $51.8 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 518.38% year-over-year to $51.8 million; the TTM value through Dec 2025 reached $51.8 million, up 518.38%, while the annual FY2025 figure was $51.8 million, 518.38% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $51.8 million at Rocket Pharmaceuticals, up from $14.6 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $51.8 million in Q4 2025 and bottomed at -$29.1 million in Q1 2021.
  • The 5-year median for Other Gross PP&E Adjustments is $14.5 million (2021), against an average of $14.8 million.
  • The largest annual shift saw Other Gross PP&E Adjustments tumbled 386.32% in 2021 before it skyrocketed 518.38% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $14.4 million in 2021, then rose by 13.53% to $16.3 million in 2022, then soared by 164.83% to $43.3 million in 2023, then tumbled by 80.67% to $8.4 million in 2024, then surged by 518.38% to $51.8 million in 2025.
  • Per Business Quant, the three most recent readings for RCKT's Other Gross PP&E Adjustments are $51.8 million (Q4 2025), $14.6 million (Q3 2025), and $43.8 million (Q2 2025).